Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | NVL-655 |
| Trade Name | |
| Synonyms | NVL655|NUV-655|NUV655|Neladalkib |
| Drug Descriptions |
NVL-655 is a brain-penetrant inhibitor of ALK, with activity against ALK fusions and mutations, which may result in decreased cell growth and tumor regression (PMID: 39269178). |
| DrugClasses | ALK Inhibitor 33 |
| CAS Registry Number | 2739866-40-9 |
| NCIT ID | C188054 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| NVL-655 | NVL-655 | 40 | 3 |